For many patients diagnosed with locally advanced lung cancer, surgery may no longer appear possible when a tumor has invaded major blood vessels, bronchi, or other critical structures.
However, advances in multidisciplinary cancer treatment are creating new possibilities for carefully selected patients.
In 2018, a 52-year-old patient, referred to as Mr. Wang to protect his privacy, was diagnosed with advanced lung cancer during a routine medical examination. The diagnosis came unexpectedly at a time when he was managing two factories and enjoying a stable family life in Shenzhen.
Eight years after undergoing a complex procedure known as autologous lung transplantation, his latest imaging results showed no definitive evidence of tumor recurrence or metastasis.
A Tumor Involving Critical Pulmonary Structures
Further examinations showed that Mr. Wang had squamous cell carcinoma in the upper lobe of his left lung.
The tumor had already invaded or closely involved several important structures, including:
- The left main pulmonary artery
- The left main bronchus
- The left pulmonary vein
- Structures around the pulmonary hilum
Under these circumstances, conventional lung cancer surgery carried significant risks. Removing the entire affected area could have resulted in the loss of too much functioning lung tissue, while incomplete removal might not have achieved adequate tumor control.
The medical team therefore organized a multidisciplinary consultation involving specialists from cardiothoracic surgery, oncology, medical imaging, anesthesiology, respiratory and critical care medicine, pathology, and nuclear medicine.
Neoadjuvant Therapy Created an Opportunity for Surgery
After reviewing the patient’s condition, the multidisciplinary team decided to begin with two cycles of neoadjuvant chemotherapy.
Neoadjuvant therapy refers to treatment given before surgery. Its purpose is often to reduce the size or extent of a tumor, control the disease, and potentially create better conditions for surgical removal.
Following two treatment cycles, Mr. Wang’s tumor decreased in size and the disease was partially controlled.
This response provided a possible window for surgery. Nevertheless, the tumor remained closely connected to the major vessels and bronchi at the pulmonary hilum. A conventional resection still could not easily achieve both complete tumor removal and preservation of adequate lung function.
The surgical team therefore considered a highly specialized alternative: autologous lung transplantation for advanced lung cancer.
What Is Autologous Lung Transplantation?
Autologous lung transplantation is fundamentally different from a conventional donor lung transplant.
The procedure uses the patient’s own lung rather than a donor organ. During surgery, the affected lung is removed from the body. Surgeons then perform precise tumor resection and reconstruction outside the body before reimplanting the remaining healthy lung tissue.
The process may include:
- Removing the affected lung.
- Excising the tumor-bearing lobe and involved tissue.
- Reconstructing the remaining bronchial and vascular structures.
- Reimplanting the preserved healthy lung tissue.
- Reconnecting the pulmonary vessels and bronchus.
This technique may allow surgeons to remove tumors that are difficult to treat through conventional resection while preserving more functional lung tissue.
However, it is an extremely demanding operation. It requires advanced thoracic surgical skills, precise vascular and bronchial reconstruction, experienced anesthesiology support, and close perioperative critical care.
Surgery Was Only One Part of the Treatment
Mr. Wang successfully completed the operation after detailed preoperative planning and close cooperation among several medical departments.
However, surgery alone was not considered sufficient.
After the procedure, he continued to receive comprehensive treatment, including chemotherapy and immunotherapy. He remained in stable condition for approximately three years.
In 2021, the disease recurred. The medical team administered additional chemotherapy, and the tumor was brought under control again.
This part of the case is important because it demonstrates that long-term cancer management may involve several treatment stages. Even after major surgery, patients generally require regular follow-up examinations and may need additional systemic treatment depending on their individual condition.
Eight Years Later: Imaging Consistent With Complete Remission
After several years without contact, Mr. Wang recently returned to the Department of Cardiothoracic Surgery at Southern Medical University Shenzhen Hospital for follow-up.
The medical team was encouraged to see him in good general condition eight years after the original diagnosis and operation.
Whole-body imaging showed:
- No definitive hypermetabolic tumor lesions
- No clear signs of recurrence
- No identified distant metastasis
- Lymph node findings consistent with post-treatment changes
According to the case report, these imaging findings were consistent with a highly satisfactory recovery status and complete tumor remission.
What Can Patients Learn From This Case?
Mr. Wang’s experience does not mean that autologous lung transplantation is suitable for every person with advanced lung cancer.
Eligibility depends on many factors, including:
- The precise location and extent of the tumor
- Whether distant metastasis is present
- The response to preoperative systemic therapy
- Remaining lung function
- Cardiovascular health
- The patient’s overall physical condition
- The experience of the surgical and multidisciplinary teams
Nevertheless, this case demonstrates that some patients initially considered unsuitable for conventional surgery may still have treatment opportunities after a comprehensive multidisciplinary evaluation.
For complex lung cancer cases, obtaining a second opinion from an experienced thoracic oncology team may help patients understand whether surgery, chemotherapy, immunotherapy, radiotherapy, targeted therapy, or a combined treatment strategy could be considered.
Seeking Advanced Lung Cancer Treatment in China?
Patients considering lung cancer treatment in China may benefit from having their medical records reviewed before traveling.
Our international medical coordination team can assist with:
- Medical record collection and translation
- Remote specialist consultation
- Multidisciplinary case review
- Hospital and physician matching
- Treatment appointment coordination
- Visa and travel guidance
- Interpretation during medical visits
- Follow-up communication after treatment
Every patient’s condition is different. Treatment recommendations should only be made after specialists review pathology reports, imaging examinations, previous treatment records, and the patient’s current health status.
Contact us to request a preliminary medical evaluation and learn more about advanced lung cancer treatment options in China.